Blue Ridge Capital’s Thermo Fisher Scientific TMO Stock Holding History

Blue Ridge Capital’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1,090,000	Closed	-$133M	–	52
2015 Q3	$133M	Sell	1,090,000 -100,000	-8%	-$13M	1.53%	34
2015 Q2	$154M	Sell	1,190,000 -760,000	-39%	-$99.1M	1.74%	28
2015 Q1	$262M	Sell	1,950,000 -165,000	-8%	-$21.3M	2.99%	13
2014 Q4	$265M	Sell	2,115,000 -600,000	-22%	-$73M	3.21%	10
2014 Q3	$330M	Hold	2,715,000	–	–	3.91%	7
2014 Q2	$320K	Sell	2,715,000 -210,000	-7%	-$24.7M	3.16%	11
2014 Q1	$352M	Sell	2,925,000 -500,000	-15%	-$59.4M	3.89%	6
2013 Q4	$381M	Sell	3,425,000 -275,000	-7%	-$27.3M	3.93%	3
2013 Q3	$341M	Sell	3,700,000 -385,000	-9%	-$34.8M	4.07%	3
2013 Q2	$346M	Buy	+4,085,000	New	+$340M	4.17%	1

Other funds holding TMO

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Blue Ridge Capital's TMO Position: Q4 2015 in Review

Blue Ridge Capital sold out of Thermo Fisher Scientific (TMO) in Q4 2015, closing a stake of 1,090,000 shares — an estimated $133M sold.

Blue Ridge Capital first reported a position in TMO in Q2 2013 and held it in 10 quarters. The position peaked at $381M in Q4 2013. 1,006 funds tracked by Wall St. Rank hold TMO as of Q4 2015.

Blue Ridge Capital reported no remaining Thermo Fisher Scientific position as of Q4 2015 after selling out during the quarter.
Blue Ridge Capital sold 1,090,000 Thermo Fisher Scientific shares in Q4 2015, an estimated $133M.
Blue Ridge Capital first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 10 quarters.
Blue Ridge Capital's Thermo Fisher Scientific position peaked at $381M in Q4 2013.
1,006 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2015.

Based on Blue Ridge Capital's 13F filing for Q4 2015, filed 16 Feb 2016.